These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18512732)

  • 21. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell.
    Parvin A; Hao SL; Tan FQ; Yang WX
    Gene; 2020 Nov; 760():144989. PubMed ID: 32717307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-prostate cancer effect of roemerine: An experimental study].
    Ma HB; Tian ZS; Gui SL; Cui WG; Li W
    Zhonghua Nan Ke Xue; 2017 Jan; 23(1):27-33. PubMed ID: 29658233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression.
    Nazari MHD; Heidarian R; Masoudnia M; Dastjerdi RA; Talkhounche PG; Taleahmad S
    Sci Rep; 2024 Aug; 14(1):18977. PubMed ID: 39152150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-trityl-L-cysteine, a novel Eg5 inhibitor, is a potent chemotherapeutic strategy in neuroblastoma.
    Wu W; Jingbo S; Xu W; Liu J; Huang Y; Sheng Q; Lv Z
    Oncol Lett; 2018 Jul; 16(1):1023-1030. PubMed ID: 29963178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
    Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
    Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells
    Lv G; Sun D; Zhang J; Xie X; Wu X; Fang W; Tian J; Yan C; Wang H; Fu F
    Acta Pharm Sin B; 2017 Jan; 7(1):52-58. PubMed ID: 28119808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer.
    Sicard G; Paris C; Giacometti S; Rodallec A; Ciccolini J; Rocchi P; Fanciullino R
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinesin Eg5 Selective Inhibition by Newly Synthesized Molecules as an Alternative Approach to Counteract Breast Cancer Progression: An In Vitro Study.
    Ricci A; Cataldi A; Carradori S; Zara S
    Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors.
    Bodun DS; Omoboyowa DA; Omotuyi OI; Olugbogi EA; Balogun TA; Ezeh CJ; Omirin ES
    Comput Biol Chem; 2023 Jun; 104():107865. PubMed ID: 37062146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer drug therapy and stochastic modeling of "nano-motors".
    Sherin L; Farwa S; Sohail A; Li Z; Bég OA
    Int J Nanomedicine; 2018; 13():6429-6440. PubMed ID: 30410329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin B-activatable cyclic antisense oligonucleotides for cell-specific target gene knockdown
    Wang Z; Fan X; Mu G; Zhao X; Wang Q; Wang J; Tang X
    Mol Ther Nucleic Acids; 2023 Sep; 33():548-558. PubMed ID: 37588686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions.
    Ricci A; Carradori S; Cataldi A; Zara S
    Biochem Res Int; 2024; 2024():3649912. PubMed ID: 38939361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor Potential of the Isoflavonoids (+)- and (-)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies.
    Farias K; da Costa RF; Meira AS; Diniz-Filho J; Bezerra EM; Freire VN; Guest P; Nikahd M; Ma X; Gardiner MG; Banwell MG; de Oliveira MDCF; de Moraes MO; do Ó Pessoa C
    ACS Med Chem Lett; 2020 Jun; 11(6):1274-1280. PubMed ID: 32551011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction for Muretta et al., A posttranslational modification of the mitotic kinesin Eg5 that enhances its mechanochemical coupling and alters its mitotic function.
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2665. PubMed ID: 29507253
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.
    Bernal L; Pinzi L; Rastelli G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
    Li Z; Yu B; Qi F; Li F
    Front Oncol; 2021; 11():670218. PubMed ID: 33968780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-186-5p represses neuroblastoma cell growth via downregulation of
    Zhu K; Su Y; Xu B; Wang Z; Sun H; Wang L; Sun C; He X
    Am J Transl Res; 2019; 11(4):2245-2256. PubMed ID: 31105832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Biphenyl-Type Inhibitors Targeting the Eg5 α4/α6 Allosteric Pocket.
    Gao C; Lowndes NF; Eriksson LA
    ACS Omega; 2017 May; 2(5):1836-1849. PubMed ID: 30023646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Methylation Patterns in Androgen-Independent Prostate Cancer Cells: A Comprehensive Analysis Combining MeDIP-Bisulfite, RNA, and microRNA Sequencing Data.
    Wang Y; Qin T; Hu W; Chen B; Dai M; Xu G
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29324665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinesin family member 11 contributes to the progression and prognosis of human breast cancer.
    Pei YY; Li GC; Ran J; Wei FX
    Oncol Lett; 2017 Dec; 14(6):6618-6626. PubMed ID: 29181100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.